Pharma
Our Collaboration Print PDF

In addition to pursuing its own internal drug discovery programs , Hybrigenics collaborates with pharmaceutical and biotechnology companies for joint research and product development.

Partnering opportunities with Hybrigenics are multiple and include:
  > Protein interaction mapping , functional exploration of disease-related pathways
  > Preclinical research from target identification to chemical screening and optimization
  > Discovery and co-development of breakthrough drugs in oncology

For more information on Hybrigenics’ programs, research platforms and partnering possibilities please contact: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

 
Meet us  at the International Conference 'Drug targets in the Ubiquitin Proteasome System; Targeting the ubiquitin system for drug discovery and development' (March 10-12, 2008; Berlin, Germany). An oral presentation will be given during the session 'E3 Ligase and DUB inhibitors' scheduled for 2:00 p.m. - 5:00 p.m. on Wednesday12th March.
© 2008 hybrigenics